Myeloid Sarcoma — Trials

Myeloid Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

13 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 4
Ph III recruiting: 0
Growth YoY: —
Industry share: 20%
Top sponsor: Kura Oncology, Inc.
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01371981	Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia	completed	Phase 3	1,645	National Cancer Institute (NCI)NIH	5	Jun 2, 2026	clinicaltrials
NCT02658487	Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia(VITAL)	completed	Phase 2	42	Vanderbilt-Ingram Cancer CenterOTHER	1	Apr 15, 2025